Arcadia Biosciences (NASDAQ:RKDA) Issues Quarterly Earnings Results

Arcadia Biosciences (NASDAQ:RKDA) announced its earnings results on Thursday. The basic materials company reported $0.29 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.46) by $0.75, FiscalAI reports. Arcadia Biosciences had a negative net margin of 234.53% and a negative return on equity of 183.50%. The company had revenue of $1.62 million for the quarter, compared to analysts’ expectations of $2.40 million.

Arcadia Biosciences Price Performance

RKDA stock opened at $0.22 on Friday. The business has a 50 day simple moving average of $0.28 and a 200-day simple moving average of $0.93. The firm has a market capitalization of $535,020.00, a PE ratio of -0.05 and a beta of 0.63. Arcadia Biosciences has a 1 year low of $0.11 and a 1 year high of $3.87.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Arcadia Biosciences in a research report on Tuesday, September 22nd. One analyst has rated the stock with a Sell rating. According to data from MarketBeat.com, the stock has an average rating of “Sell”.

About Arcadia Biosciences

Arcadia Biosciences, Inc. is an agricultural biotechnology company focused on developing and commercializing food ingredients and crop-based products intended to support health and wellness. The company applies plant science and breeding technologies to develop crops with enhanced nutritional characteristics and products designed for consumer and food-industry applications. Its product portfolio has included GoodWheat, a wheat variety developed with increased dietary fiber and other nutritional attributes, as well as GoodHemp, a line of hemp-based food products and ingredients.